Liver transplant, weight-loss surgery combination benefits obese patients in long term

October 2, 2018 by Heather Carlson Kehren, Mayo Clinic

Obese patients who underwent a life-saving liver transplant and weight-loss surgery at the same time were better able to keep the weight off long term and had fewer metabolic complications than those who lost weight on their own before undergoing a liver transplant, Mayo Clinic research shows. The findings were recently published in Hepatology.

"This study shows that the combined approach of and weight-loss surgery is safe and effective over the long term," says senior author Julie K. Heimbach, M.D., a transplant surgeon and division chair of Transplant Surgery at Mayo Clinic.

As obesity rates in the U.S. have soared, so have the number of people diagnosed with nonalcoholic fatty liver disease—a range of that affects people who drink little to no alcohol and results in too much fat stored in . An estimated 80 to 100 million Americans have been diagnosed with this . Historically, severely obese patients who are unable to lose the necessary weight have been denied access to a liver transplant because obesity can increase surgical risks and is a potential risk factor for post-transplant complications. In other instances, the transplants are performed without addressing a patient's weight problem, which can lead to liver disease in the future and jeopardize the success of the transplant.

The study involved a total of 49 adults with a body mass index of more than 35 kg/m2 who were referred to Mayo Clinic for a liver transplant since 2006. Of those patients, 36 were able to lose enough weight to achieve a BMI of less than 35 kg/m2 and underwent a liver transplant alone. Overall, there were 29 patients who were unable to lose sufficient weight prior to transplant and thus underwent a combined liver transplant and sleeve gastrectomy, with 13 of them being at least three years or more from the time of the surgery, which was the focus of the study. Sleeve gastrectomy is a type of weight-loss surgery that reduces the size of the stomach by about 80 percent.

Researchers found that, while patients who underwent the liver transplant alone experienced significant weight loss before surgery, they steadily gained weight afterwards. The percentage of total body weight gained ended up being higher among those patients who had the liver transplant alone compared to those who underwent both a liver transplant and . Three years after surgery, patients who had the liver transplant alone maintained a weight loss of a median of 3.9 percent of their total body weight compared to 34.8 percent for patients who had the transplant and . In addition, those patients who had the dual surgery were less likely to have high blood pressure, insulin resistance and fatty liver. They needed less medication to lower blood pressure and cholesterol.

"Obesity-related liver disease is one of the most common and rapidly increasing reasons that people need a . Even though most obese people will not need a transplant, for those who develop advanced liver disease, we need to have an approach that treats not only the liver disease but the cause of the liver disease," says Dr. Heimbach.

Explore further: More protein after weight loss may reduce fatty liver disease

Related Stories

More protein after weight loss may reduce fatty liver disease

August 16, 2018
Increasing the amount of protein in the diet may reduce the liver's fat content and lower the risk of diabetes in people with nonalcoholic fatty liver disease (NAFLD). The study is published ahead of print in the American ...

New anti-rejection drug reduces weight gain and enhances outcomes for liver transplant recipients

May 2, 2017
Researchers have discovered that a new anti-rejection drug that is gentler on the kidneys after liver transplant also reduces weight gain, which is common after surgery and can lead to serious complications for transplant ...

Transplanted livers help body defend against organ rejection, study finds

April 18, 2018
For decades, transplant experts have observed that liver transplant recipients often need less anti-rejection medication, known as immunosuppressive drugs, than recipients of other solid organs. Similarly, when patients receive ...

Survivors of childhood liver transplant at risk of becoming 'skinny fat'

June 12, 2014
New research reports that survivors of childhood liver transplant remain nutritionally compromised over the long-term. Findings published in Liver Transplantation, a journal of the American Association for the Study of Liver ...

Morbidity higher in obese liver transplant recipients with diabetes, survival not impacted

January 23, 2014
Researchers from New Zealand report that morbidity following liver transplant is highest among obese patients with diabetes, but these risk factors do not influence post-transplant survival. According to the study published ...

US study reports dramatic reduction in likelihood of liver transplantation in patients with hepatoce

April 13, 2018
Patients with hepatocellular carcinoma (HCC) waiting for a liver transplant in the USA are now significantly less likely to receive a new liver than they were around a decade ago. A nationwide study presented today at The ...

Recommended for you

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.